论文部分内容阅读
AIM:Clinical application and potential complication ofpercutaneous transsplenic varices embolization(PTSVE)ofesophageal or gastrio-fundal varices in patients withhepetooellular carcinoma(HCC)complicated with portalvein cancerous thrombosis(PVCT).METHODS:18 patients with HCC complicated with PVCT andesophageal or gastrio-fundal varices who underwent PTSVEwore collected.The rate of success,complication,mortalityof the procedure and postoperative complication wererecorded and analyzed.RESULTS:PTSVE were successfully performed in 16 of 18cases,and the rate of success was 89%.After therapyerythrocyte counts decreased in all of the natunts.5 ofpatients needed blood transfusion,2 patientsrequiredsurgical intervention because of and 11 patients withascites were alleviated by diuresis.Among these 18patients,the procedure-related mortality was 11%(2/18),one died of acute hepatic failure on the forth day afterprocedure,another died of acute renal failure on the fifthday.The patients were follow up for 112 mon exceptone.13of them died of their tumors but none of them experiencedvariceel bleeding.CONCLUSION:PTSVE Is a relatively safe and effectivemethod to treat esophageal or gastrio-fundal varices in HCCpatients with PVCT when percutaneous transhepatic varicesembolization(PTHVE)of varices is impossible.
AIM: Clinical application and potential complication ofpercutaneous transsplenic varices embolization(PTSVE)ofesophageal or gastrio-fundal varices in patients withhepetooellular carcinoma(HCC)complicated with portalvein cancerous thrombosis(PVCT).METHODS:18 patients with HCC complicated with PVCT andesophageal or gastrio-fundal Varices who underwent PTSVEwore collected.The rate of success,complication,mortalityof the procedure and postoperative complication wererecorded and analyzed.RESULTS:PTSVE were successfully performed in 16 of 18cases,and the rate of success was 89%.After therapyerythrocyte counts decreased in all of The natunts.5 ofpatients needed blood transfusion,2 patientsrequiredsurgical intervention because of and 11 patients withascites were neededd by diuresis.Among these 18patients,the procedure-related mortality was 11%(2/18),one died of acute hepatic failure on the forth Day afterprocedure, another died of acute renal failure on the fifthday.The patients were follow u p for 112 mon exceptone.13 of them died of their tumors but none of them sufferingvariemel bleeding.CONCLUSION: PTSVE Is a relatively safe and effectivemethod to treat esophageal or gastrio-fundal varices in HCCpatients with PVCT when percutaneous transhepatic varicesembolization(PTHVE)of varices is Impossible.